Epidemiology of hepatocellular carcinoma and cholangiocarcinoma

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third cause of cancer-related deaths worldwide. Cholangiocarcinoma (CCA) is the second most common primary liver tumor and is less common than HCC. The latest data from the Surveillance, Epidemiology and End Results (SEER) program, a population-based study on cancer incidence, prevalence, and mortality in the United States, show that primary liver cancer (90% HCC and 10% CCA) is one of few tumors with a rising incidence over the last 10 years (Figure 1.1). We herein discuss the epidemiology and risk factors for these tumors. Hepatocellular carcinoma The largest concentration of HCC cases in the world is in Asia, followed by Africa, Europe, and North and South America. The incidence of HCC varies among ethnic groups, with increasing incidence rates found in Japanese (5.5/100 000 in men and 4.3/100 000 in women), African American (7.1/100 000 in men and 2.1/100 000 in women), Hispanic (9.8/100 000 in men and 3.5/100 000 in women), and Chinese (16.2/100 000 in men and 5/100 000 in women) populations. Even though the incidence rate is greater in men compared to women, there is a 2- to 5-fold higher incidence rate among women of various ethnicities compared to non-Hispanic white women. During the last two decades, an increasing trend in the incidence of HCC has been noted in Australia, Central Europe, the United Kingdom, Japan, and North America.

Original languageEnglish (US)
Title of host publicationPrimary Carcinomas of the Liver
PublisherCambridge University Press
Pages1-9
Number of pages9
Volume9780521519519
ISBN (Print)9780511770807, 9780521519519
DOIs
StatePublished - Jan 1 2009

Fingerprint

Cholangiocarcinoma
Hepatocellular Carcinoma
Epidemiology
Incidence
Neoplasms
North America
SEER Program
South America
Liver Neoplasms
Hispanic Americans
Ethnic Groups
African Americans
Population
Japan
Mortality
Liver

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Marrero, J. A. (2009). Epidemiology of hepatocellular carcinoma and cholangiocarcinoma. In Primary Carcinomas of the Liver (Vol. 9780521519519, pp. 1-9). Cambridge University Press. https://doi.org/10.1017/CBO9780511770807.003

Epidemiology of hepatocellular carcinoma and cholangiocarcinoma. / Marrero, Jorge A.

Primary Carcinomas of the Liver. Vol. 9780521519519 Cambridge University Press, 2009. p. 1-9.

Research output: Chapter in Book/Report/Conference proceedingChapter

Marrero, JA 2009, Epidemiology of hepatocellular carcinoma and cholangiocarcinoma. in Primary Carcinomas of the Liver. vol. 9780521519519, Cambridge University Press, pp. 1-9. https://doi.org/10.1017/CBO9780511770807.003
Marrero JA. Epidemiology of hepatocellular carcinoma and cholangiocarcinoma. In Primary Carcinomas of the Liver. Vol. 9780521519519. Cambridge University Press. 2009. p. 1-9 https://doi.org/10.1017/CBO9780511770807.003
Marrero, Jorge A. / Epidemiology of hepatocellular carcinoma and cholangiocarcinoma. Primary Carcinomas of the Liver. Vol. 9780521519519 Cambridge University Press, 2009. pp. 1-9
@inbook{8149e4ee9fcd4e5d83de3ee7fcfb46a3,
title = "Epidemiology of hepatocellular carcinoma and cholangiocarcinoma",
abstract = "Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third cause of cancer-related deaths worldwide. Cholangiocarcinoma (CCA) is the second most common primary liver tumor and is less common than HCC. The latest data from the Surveillance, Epidemiology and End Results (SEER) program, a population-based study on cancer incidence, prevalence, and mortality in the United States, show that primary liver cancer (90{\%} HCC and 10{\%} CCA) is one of few tumors with a rising incidence over the last 10 years (Figure 1.1). We herein discuss the epidemiology and risk factors for these tumors. Hepatocellular carcinoma The largest concentration of HCC cases in the world is in Asia, followed by Africa, Europe, and North and South America. The incidence of HCC varies among ethnic groups, with increasing incidence rates found in Japanese (5.5/100 000 in men and 4.3/100 000 in women), African American (7.1/100 000 in men and 2.1/100 000 in women), Hispanic (9.8/100 000 in men and 3.5/100 000 in women), and Chinese (16.2/100 000 in men and 5/100 000 in women) populations. Even though the incidence rate is greater in men compared to women, there is a 2- to 5-fold higher incidence rate among women of various ethnicities compared to non-Hispanic white women. During the last two decades, an increasing trend in the incidence of HCC has been noted in Australia, Central Europe, the United Kingdom, Japan, and North America.",
author = "Marrero, {Jorge A.}",
year = "2009",
month = "1",
day = "1",
doi = "10.1017/CBO9780511770807.003",
language = "English (US)",
isbn = "9780511770807",
volume = "9780521519519",
pages = "1--9",
booktitle = "Primary Carcinomas of the Liver",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - Epidemiology of hepatocellular carcinoma and cholangiocarcinoma

AU - Marrero, Jorge A.

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third cause of cancer-related deaths worldwide. Cholangiocarcinoma (CCA) is the second most common primary liver tumor and is less common than HCC. The latest data from the Surveillance, Epidemiology and End Results (SEER) program, a population-based study on cancer incidence, prevalence, and mortality in the United States, show that primary liver cancer (90% HCC and 10% CCA) is one of few tumors with a rising incidence over the last 10 years (Figure 1.1). We herein discuss the epidemiology and risk factors for these tumors. Hepatocellular carcinoma The largest concentration of HCC cases in the world is in Asia, followed by Africa, Europe, and North and South America. The incidence of HCC varies among ethnic groups, with increasing incidence rates found in Japanese (5.5/100 000 in men and 4.3/100 000 in women), African American (7.1/100 000 in men and 2.1/100 000 in women), Hispanic (9.8/100 000 in men and 3.5/100 000 in women), and Chinese (16.2/100 000 in men and 5/100 000 in women) populations. Even though the incidence rate is greater in men compared to women, there is a 2- to 5-fold higher incidence rate among women of various ethnicities compared to non-Hispanic white women. During the last two decades, an increasing trend in the incidence of HCC has been noted in Australia, Central Europe, the United Kingdom, Japan, and North America.

AB - Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third cause of cancer-related deaths worldwide. Cholangiocarcinoma (CCA) is the second most common primary liver tumor and is less common than HCC. The latest data from the Surveillance, Epidemiology and End Results (SEER) program, a population-based study on cancer incidence, prevalence, and mortality in the United States, show that primary liver cancer (90% HCC and 10% CCA) is one of few tumors with a rising incidence over the last 10 years (Figure 1.1). We herein discuss the epidemiology and risk factors for these tumors. Hepatocellular carcinoma The largest concentration of HCC cases in the world is in Asia, followed by Africa, Europe, and North and South America. The incidence of HCC varies among ethnic groups, with increasing incidence rates found in Japanese (5.5/100 000 in men and 4.3/100 000 in women), African American (7.1/100 000 in men and 2.1/100 000 in women), Hispanic (9.8/100 000 in men and 3.5/100 000 in women), and Chinese (16.2/100 000 in men and 5/100 000 in women) populations. Even though the incidence rate is greater in men compared to women, there is a 2- to 5-fold higher incidence rate among women of various ethnicities compared to non-Hispanic white women. During the last two decades, an increasing trend in the incidence of HCC has been noted in Australia, Central Europe, the United Kingdom, Japan, and North America.

UR - http://www.scopus.com/inward/record.url?scp=84898402215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898402215&partnerID=8YFLogxK

U2 - 10.1017/CBO9780511770807.003

DO - 10.1017/CBO9780511770807.003

M3 - Chapter

SN - 9780511770807

SN - 9780521519519

VL - 9780521519519

SP - 1

EP - 9

BT - Primary Carcinomas of the Liver

PB - Cambridge University Press

ER -